Stay updated on Combination Dato-DXd Clinical Trial

Sign up to get notified when there's something new on the Combination Dato-DXd Clinical Trial page.
Screenshot error
Open in browserReport Problem
Clouds background image

Latest updates to the Combination Dato-DXd Clinical Trial page

  1. Check
    12 days ago
    Change Detected
    Summary
    The website has updated to version v2.14.0, adding a 'Contact: Principal Investigator' section and a new 'Type of intervention' feature, while removing the previous version's 'type of intervention' and reverting to an earlier revision.
    Difference
    11%
    Check dated 2025-01-08T13:10:10.000Z thumbnail image
  2. Check
    34 days ago
    Change Detected
    Summary
    The study has increased from 236 to 237 locations, with the latest revision updated to v2.13.3.
    Difference
    0.4%
    Check dated 2024-12-17T16:38:12.000Z thumbnail image
  3. Check
    41 days ago
    Change Detected
    Summary
    The website has updated the contact details section for the study, clarifying that it now provides information on who can answer questions about joining the study and where it is taking place, with a reference to the Contacts and Locations section.
    Difference
    1.0%
    Check dated 2024-12-10T13:26:15.000Z thumbnail image
  4. Check
    48 days ago
    Change Detected
    Summary
    The website has removed the 'Last Update Posted (Estimated)' section and replaced it with a definitive 'Last Update Posted' section.
    Difference
    0.0%
    Check dated 2024-12-03T08:00:34.000Z thumbnail image
  5. Check
    55 days ago
    Change Detected
    Summary
    Two new studies have been added, one in Avignon, France, and another in Craiova, Romania, both currently recruiting participants.
    Difference
    2%
    Check dated 2024-11-26T05:03:27.000Z thumbnail image
  6. Check
    63 days ago
    Change Detected
    Summary
    A new study has been added to assess the efficacy and safety of datopotamab deruxtecan in combination with pembrolizumab for advanced non-small cell lung cancer, with a focus on participants without actionable genomic alterations and high PD-L1 expression, while previous details about a similar study have been removed.
    Difference
    17%
    Check dated 2024-11-18T15:32:16.000Z thumbnail image

Stay in the know with updates to Combination Dato-DXd Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Combination Dato-DXd Clinical Trial page.